Do plasma leptin levels predict diastolic dysfunction in patients with hypertension?

Archives of Medical Science

Volumn 5, Issue 3, 2009, Pages 342-346

  Tatli, Ersan ^a   Aktoz, Meryem ^a   Altun, Armaǧan ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

Diastolic dysfunction; Hypertension; Leptin

Indexed keywords

GLUCOSE; INSULIN; LEPTIN; THYROID HORMONE;

ADULT; ARTICLE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; ELECTROCARDIOGRAPHY; HEART EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT;

EID: 73449092501     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Friedman JM. Leptin, leptin receptors and the control of body weight. Eur J Med Res 1997; 2: 7-13.
2. Halaas JL, Gajiwala KS, Maffei M, et al. Weight reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-6.
3. Agata J, Masuda A, Takada M, et al. High plasma immunoreactive leptin level in essential hypertension. Am J Hypertens 1997; 10: 1171-4.
4. Casto RM, VanNess JM, Overton JM. Effects of central leptin administration on blood pressure in normotensive rats. Neurosci Lett 1998; 246: 29-32.
5. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension 1998; 31: 409-14.
6. World Health Organization: Diabetes Mellitus, World Health Organization, 1985, vol. 727; 9-17.
7. Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degree glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57-63.
8. Mather KJ, Hunt AE, Steinberg HO, et al. Repeatability characteristics of simple indices of insulin resistance: implications for research applications. J Clin Endocrinol Metab 2001; 86: 5457-64.
9. Ma Z, Gingerich RL, Santiago JV, Klein S, Smith CH, Landt M. Radioimmunoassay of leptin in human plasma. Clin Chem 1996; 42: 942-6.
10. Mendoza-Núñez VM, Garcia-Sanchez A, Sanchez-Rodriguez MA, Galvan-Duarte R, Fonseca-Yerena E. Overweight, waist circumference, age, gender, and insulin resistance as risk factors for hyperleptinemia. Obes Res 2002; 10: 253-9.
11. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-67.
12. Garcia MJ, Thomas J, Klein AL. New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol 1998; 32: 865-75.
13. Jain A, Avendano G, Dharamsey S, et al. Left ventricular diastolic function in hypertension and role of plasma glucose and insulin: comparison with diabetic heart. Circulation 1996; 93: 1396-402.
14. Lind L, Anderson G, Anden B, Hanni A, Lithell HO. Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome. J Hypertens 1995; 13: 433-8.
15. Cohn JN, Johnson G. Heart failure with normal ejection fraction: the V-Heft Study. Circulation 1990; 81 (2 Suppl): III48-53.
16. Iriarte M, Munga N, Sagastogoitia D. Congestive heart failure from left ventricular diastolic dysfunction in systemic hypertension. Am J Cardiol 1993; 71: 308-12.
17. Ren J, Relling DP. Leptin-induced suppression of cardiomyocyte contraction is amplified by ceramide. Peptides 2006; 27: 1415-9.
18. Narkiewicz K, Somers VK, Mos L, et al. An independent relationship between plasma leptin and heart rate in untreated patients with essential hypertension. J Hypertens 1999; 17: 245-9.
19. Ren J. Leptin and hyperleptinemia - from friend to foe for cardiovascular function. J Endocrinol 2004; 181: 1-10.
20. Galderisi M, Tagliamonte MR, D'Errico A, et al. Independent association of plasma leptin levels and left ventricular isovolumic relaxation in uncomplicated hypertension. Am J Hypertens 2001; 14: 1019-24.